Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Key takeaways Retatrutide isn't approved yet and isn't expected to launch in the UK until at least mid-2026 In clinical trials, target doses ranged from 0.5mg to 12mg weekly, with the most common being 4mg, 8mg, 9mg and 12mg Different dosing schedules were tested, with most people starting at 2mg and escalating every 4 weeks The 12mg dose produced the most weight loss (up to 28.7% after 68 weeks) Starting at 2mg rather than 4mg helped reduce side effects during escalation First to know Get an email the day retatrutide launches in the UK
Losing hair is a natural phenomenon: each day, it is normal to lose 50 to 100 hairs
Semaglutide for managing overweight and obesity (TA875) Chapter 1: Recommendations
Stop Microdosing Retatrutide Thats Not How the Science Works Theres a growing trend that needs to be addressed: People are microdosing Retatrutide daily and expecting full results
For a product page, the safer takeaway is documentation-based
Women with prior bariatric surgery, pregnancy before the index date, incomplete weight data, or other weight-loss medication use were excluded
